Biovica attends ASCO in Chicago
ASCO brings together more than 32,000 oncology professionals from across the globe to share the latest clinical cancer research impacting patient care.
The Biovica team will attend the ASCO (American Society of Clinical Oncology) Annual Meeting in Chicago May 31-June 4. Take the opportunity to learn more about DiviTum®, our blood-based biomarker for evaluating modern cancer therapies and how it can support your oncology development projects.
Contact firstname.lastname@example.org to book a meeting on site.